These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15014512)

  • 1. Making big money from small technology.
    Hsiao JC; Fong K
    Nature; 2004 Mar; 428(6979):218-20. PubMed ID: 15014512
    [No Abstract]   [Full Text] [Related]  

  • 2. Little science, big bucks.
    DeFrancesco L
    Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
    [No Abstract]   [Full Text] [Related]  

  • 3. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 4. Investors likely to venture back as crisis subsides.
    Glick JL
    Nature; 2009 Aug; 460(7259):1079. PubMed ID: 19713912
    [No Abstract]   [Full Text] [Related]  

  • 5. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 6. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 7. Consumer products leap aboard the nano bandwagon.
    Brumfiel G
    Nature; 2006 Mar; 440(7082):262. PubMed ID: 16541037
    [No Abstract]   [Full Text] [Related]  

  • 8. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 9. Russian fund steps up investments in innovative biotechs.
    Katsnelson A
    Nat Biotechnol; 2012 Jan; 30(1):9-11. PubMed ID: 22231078
    [No Abstract]   [Full Text] [Related]  

  • 10. Hedge funds gain edge by doubling biotech investments.
    Ransom J
    Nat Biotechnol; 2006 Apr; 24(4):373-4. PubMed ID: 16601707
    [No Abstract]   [Full Text] [Related]  

  • 11. White biotech and the financial crisis.
    Rabinovich M
    Biotechnol J; 2009 Aug; 4(8):1117-23. PubMed ID: 19685465
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech holds its own in Q2.
    Lawrence S
    Nat Biotechnol; 2004 Aug; 22(8):938. PubMed ID: 15286634
    [No Abstract]   [Full Text] [Related]  

  • 13. Japanese giants renew interest in industrial biotech.
    Sipp D
    Nat Biotechnol; 2005 Mar; 23(3):275-6. PubMed ID: 15765071
    [No Abstract]   [Full Text] [Related]  

  • 14. US government previews biotech survey.
    Goho A
    Nat Biotechnol; 2003 Aug; 21(8):837-8. PubMed ID: 12894185
    [No Abstract]   [Full Text] [Related]  

  • 15. Bugs or drugs, tortoises or hares?
    Jacobs T
    Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
    [No Abstract]   [Full Text] [Related]  

  • 16. Australia--the premier Asia-Pacific hub for biotech investment.
    Watkinson N
    Drug Discov Today; 2008 Mar; 13(5-6):192-7. PubMed ID: 18342794
    [No Abstract]   [Full Text] [Related]  

  • 17. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E
    Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
    [No Abstract]   [Full Text] [Related]  

  • 18. Burning bright.
    Huggett B
    Nat Biotechnol; 2013 Dec; 31(12):1068-71. PubMed ID: 24316634
    [No Abstract]   [Full Text] [Related]  

  • 19. Boutiques reborn in 2003.
    Surendran A
    Nat Biotechnol; 2004 Mar; 22(3):353-4. PubMed ID: 15017987
    [No Abstract]   [Full Text] [Related]  

  • 20. Back to life.
    Smaglik P
    Nature; 2004 May; 429(6990):483. PubMed ID: 15164076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.